Texas Attorney General Ken Paxton is suing Eli Lilly for allegedly “bribing” doctors to prescribe the company’s most profitable drugs, including its GLP-1 weight-loss medications Mounjaro and Zepbound.
Many of the prescriptions were covered by Texas Medicaid, resulting in “millions of dollars” in claims made at taxpayers’ expense, the suit alleges.
Texas Attorney General Ken Paxton is suing Eli Lilly for allegedly “bribing” doctors to prescribe the company’s most profitable drugs, including its GLP-1 weight-loss.
The drugmaker “compromised medical decision-making by engaging in an illegal kickback scheme,” said Paxton in a press release. He added:
“Eli Lilly fraudulently sought to maximize profits at taxpayer expense and put corporate greed over people’s health. I will not stand by while corporations unlawfully manipulate our healthcare system to line their own pockets.”
Plaintiffs include the state of Texas and Health Choice Alliance LLC, a New Jersey-based research organization.
